Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls
- PMID: 1904073
- PMCID: PMC296979
- DOI: 10.1172/JCI115253
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls
Abstract
Myasthenia gravis (MG) is strongly associated with antibodies to acetylcholine receptor (AChR), whereas the extent of T cell involvement is not settled. The number of cells secreting interferon-gamma (IFN-gamma) in response to AChR during 48 h culture of blood mononuclear cells (PBL) may reflect AChR-reactive T cells. Using an immunospot assay, we detected such cells in 23 of 30 patients with MG at a mean number of 1 per 33.333 PBL. AChR-reactive T cells were also found in patients with other neurological diseases (OND) and in healthy subjects but at lower frequencies and numbers. The T cell response to purified protein derivative and to PHA, and also to two major myelin proteins (basic protein and proteolipid protein) did not differ between MG and the two control groups, underlining the specificity of an augmented T cell reactivity to AChR in MG. Evaluation of the B cell response by enumerating anti-AChR IgG antibody secreting cells revealed such cells in 27 of 28 patients with MG at a mean value of 1 per 14,085 PBL. Cells secreting anti-AChR antibodies of the IgA and IgM isotypes were also detected in MG, but less frequently, at lower numbers, and only in conjunction with IgG antibody secreting cells. Anti-AChR antibody secreting cells were also found among patient with OND and in healthy controls, but at lower frequencies and numbers. These data confirm that AChR is a major target for autoimmune response in MG.
Similar articles
-
T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls.Eur J Immunol. 1992 Jun;22(6):1553-9. doi: 10.1002/eji.1830220631. Eur J Immunol. 1992. PMID: 1376263
-
Autoreactive T and B cells in nervous system diseases.Acta Neurol Scand Suppl. 1993;142:1-56. Acta Neurol Scand Suppl. 1993. PMID: 8382894
-
Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis.J Immunol. 1992 Nov 15;149(10):3423-6. J Immunol. 1992. PMID: 1431116
-
On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.Crit Rev Immunol. 2001;21(1-3):1-27. Crit Rev Immunol. 2001. PMID: 11642597 Review.
-
Myasthenia gravis: recognition of a human autoantigen at the molecular level.Immunol Today. 1993 Jul;14(7):363-8. doi: 10.1016/0167-5699(93)90237-F. Immunol Today. 1993. PMID: 8363727 Review.
Cited by
-
Myasthenia gravis as a prototype autoimmune receptor disease.Immunol Res. 1997;16(4):341-54. doi: 10.1007/BF02786398. Immunol Res. 1997. PMID: 9439759 Review.
-
Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG).Clin Exp Immunol. 1999 Nov;118(2):304-8. doi: 10.1046/j.1365-2249.1999.01062.x. Clin Exp Immunol. 1999. PMID: 10540195 Free PMC article.
-
A cellular viewpoint of anti-FVIII immune response in hemophilia A.Clin Rev Allergy Immunol. 2009 Oct;37(2):105-13. doi: 10.1007/s12016-009-8117-2. Clin Rev Allergy Immunol. 2009. PMID: 19165635 Review.
-
Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats.Clin Exp Immunol. 1998 Jan;111(1):205-10. doi: 10.1046/j.1365-2249.1998.00467.x. Clin Exp Immunol. 1998. PMID: 9472683 Free PMC article.
-
The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.J Immunol Methods. 2014 Jul;409:31-43. doi: 10.1016/j.jim.2014.03.017. Epub 2014 Mar 28. J Immunol Methods. 2014. PMID: 24685833 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous